Overview of Stemness
Our CEO, Wendy Blosser, provides a quick primer on one of the important foundations of the proprietary StemPrintER test, tumor “stemness.”
Breast Cancer Opportunity
Genomics are broadly utilized in cancer- our CEO, Wendy Blosser, explains our mission at AccuStem and the market opportunity for StemPrintER in breast cancer.
AccuStem’s Leadership Team
Accustem’s leadership comprises successful and experienced veterans from the diagnostics space. Our CEO, Wendy Blosser, provides a brief introduction to the team.